Holen Sie sich die Stockscreener-App
14.13
8.84%
-1.37
Handel nachbörslich:
13.91
-0.22
-1.56%
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Research and Development |
1.31%
62.20
|
63.03 | 62.05 | 63.61 | 54.29 |
| Costs And Expenses |
0.87%
75.58
|
74.93 | 73.73 | 75.41 | 64.39 |
| Depreciation and Amortization |
2.34%
0.655
|
0.64 | 0.675 | 0.62 | 0.606 |
| Operating Income/Loss |
0.87%
-75.58
|
-74.93 | -73.73 | -75.41 | -64.39 |
| Nonoperating Income/Loss |
30.34%
2.053
|
2.947 | 5.807 | 4.78 | 5.437 |
| Income/Loss From Continuing Operations Before Tax |
5.00%
-75.58
|
-71.99 | -67.93 | -75.41 | -58.95 |
| Income/Loss From Continuing Operations After Tax |
2.14%
-73.53
|
-71.99 | -67.93 | -70.63 | -58.95 |
Net Income/Loss
|
2.14%
-73.53
|
-71.99 | -67.93 | -70.63 | -58.95 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.02%
114.47
|
113.31 | 2.4212 | 110.17 | 99.24 |
| Diluted Average Shares |
1.02%
114.47
|
113.31 | 2.4212 | 110.17 | 99.24 |
| Basic Earnings Per Share |
1.92%
-0.53
|
-0.52 | -0.09 | -0.64 | -0.59 |
| Diluted Earnings Per Share |
1.92%
-0.53
|
-0.52 | -0.09 | -0.64 | -0.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):